The management of heart failure should be a shared responsibility between patients, their carers and healthcare professionals
Pharmacological therapy has been shown to improve outcomes in patients with heart failure with reduced ejection fraction
Patients with heart failure with reduced ejection fraction should be treated with an angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker, beta blocker and mineralocorticoid receptor antagonist
Patients with heart failure require close monitoring
